Normal view MARC view ISBD view

Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness in Stable Coronary Artery Disease: When Are We Ready to Implement?

Luzum, Jasmine A

Pharmacogenetic Risk Scores for Perindopril Clinical and Cost Effectiveness in Stable Coronary Artery Disease: When Are We Ready to Implement? [electronic resource] - Journal of the American Heart Association Mar 2016 - e003440 p. digital

Publication Type: Editorial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Comment

ISSN: 2047-9980

Standard No.: 10.1161/JAHA.116.003440 doi

Subjects--Topical Terms:
Angiotensin-Converting Enzyme Inhibitors--therapeutic use
Coronary Artery Disease--drug therapy
Cost-Benefit Analysis
Humans
Perindopril
Pharmacogenetics

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)